Thousands of NHS cancer patients in England are expected to get access to trials of a new type of treatment using vaccines to fight their disease.It is designed to match patients with forthcoming trials using mRNA technology, as found in current Covid jabs.
Elliot, who has already had surgery and chemotherapy, received the jab at Birmingham’s Queen Elizabeth Hospital. After Elliot’s initial treatment, tests showed that he still had fragments of cancerous DNA in his bloodstream, which puts patients at increased risk of their cancer coming back.of an investigational vaccine made by German pharma company BioNTech, which uses the same mRNA technology as in the Pfizer-BioNTech Covid vaccine.But cancer vaccines are created as a treatment once someone has been diagnosed.
Using this information, a vaccine was created using mRNA, which contains instructions to Elliot’s cells to produce mutated rogue proteins unique to his cancer cells. "My hope is this will become the standard of care. It makes sense that we can have something that can help patients reduce their risk of cancer recurrence.”
Elliot said that apart from a mild fever following the injection, he had no other issues with the vaccine.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WashTimes - 🏆 235. / 63 Read more »
Source: WGAL - 🏆 331. / 59 Read more »
Source: AP - 🏆 728. / 51 Read more »
Source: ABC - 🏆 471. / 51 Read more »